RATIONALE: Recent findings have shown a complexly regulated 5-HT system as it is linked to different kinds of aggression. OBJECTIVE: We focus on (1) phasic and tonic changes of 5-HT and (2) state and trait of aggression, and emphasize the different receptor subtypes, their role in specific brain regions, feed-back regulation and modulation by other amines, acids and peptides. RESULTS: New pharmacological tools differentiate the first three 5-HT receptor families and their modulation by GABA, glutamate and CRF. Activation of 5-HT(1A), 5-HT(1B) and 5-HT(2A/2C) receptors in mesocorticolimbic areas, reduce species-typical and other aggressive behaviors. In contrast, agonists at 5-HT(1A) and 5-HT(1B) receptors in the medial prefrontal cortex or septal area can increase aggressive behavior under specific conditions. Activation of serotonin transporters reduce mainly pathological aggression. Genetic analyses of aggressive individuals have identified several molecules that affect the 5-HT system directly (e.g., Tph2, 5-HT(1B), 5-HT transporter, Pet1, MAOA) or indirectly (e.g., Neuropeptide Y, αCaMKII, NOS, BDNF). Dysfunction in genes for MAOA escalates pathological aggression in rodents and humans, particularly in interaction with specific experiences. CONCLUSIONS: Feedback to autoreceptors of the 5-HT(1) family and modulation via heteroreceptors are important in the expression of aggressive behavior. Tonic increase of the 5-HT(2) family expression may cause escalated aggression, whereas the phasic increase of 5-HT(2) receptors inhibits aggressive behaviors. Polymorphisms in the genes of 5-HT transporters or rate-limiting synthetic and metabolic enzymes of 5-HT modulate aggression, often requiring interaction with the rearing environment.
RATIONALE: Recent findings have shown a complexly regulated 5-HT system as it is linked to different kinds of aggression. OBJECTIVE: We focus on (1) phasic and tonic changes of 5-HT and (2) state and trait of aggression, and emphasize the different receptor subtypes, their role in specific brain regions, feed-back regulation and modulation by other amines, acids and peptides. RESULTS: New pharmacological tools differentiate the first three 5-HT receptor families and their modulation by GABA, glutamate and CRF. Activation of 5-HT(1A), 5-HT(1B) and 5-HT(2A/2C) receptors in mesocorticolimbic areas, reduce species-typical and other aggressive behaviors. In contrast, agonists at 5-HT(1A) and 5-HT(1B) receptors in the medial prefrontal cortex or septal area can increase aggressive behavior under specific conditions. Activation of serotonin transporters reduce mainly pathological aggression. Genetic analyses of aggressive individuals have identified several molecules that affect the 5-HT system directly (e.g., Tph2, 5-HT(1B), 5-HT transporter, Pet1, MAOA) or indirectly (e.g., Neuropeptide Y, αCaMKII, NOS, BDNF). Dysfunction in genes for MAOA escalates pathological aggression in rodents and humans, particularly in interaction with specific experiences. CONCLUSIONS: Feedback to autoreceptors of the 5-HT(1) family and modulation via heteroreceptors are important in the expression of aggressive behavior. Tonic increase of the 5-HT(2) family expression may cause escalated aggression, whereas the phasic increase of 5-HT(2) receptors inhibits aggressive behaviors. Polymorphisms in the genes of 5-HT transporters or rate-limiting synthetic and metabolic enzymes of 5-HT modulate aggression, often requiring interaction with the rearing environment.
Authors: E Potter; S Sutton; C Donaldson; R Chen; M Perrin; K Lewis; P E Sawchenko; W Vale Journal: Proc Natl Acad Sci U S A Date: 1994-09-13 Impact factor: 11.205
Authors: A Veronica Witte; Agnes Flöel; Patrycja Stein; Markus Savli; Leonhard-Key Mien; Wolfgang Wadsak; Christoph Spindelegger; Ulrike Moser; Martin Fink; Andreas Hahn; Markus Mitterhauser; Kurt Kletter; Siegfried Kasper; Rupert Lanzenberger Journal: Hum Brain Mapp Date: 2009-08 Impact factor: 5.038
Authors: Lígia Aline Centenaro; Karin Vieira; Nicolle Zimmermann; Klaus A Miczek; Aldo Bolten Lucion; Rosa Maria Martins de Almeida Journal: Psychopharmacology (Berl) Date: 2008-08-08 Impact factor: 4.530
Authors: C R Yang; Y Y Bai; C S Ruan; H F Zhou; D Liu; X F Wang; L J Shen; H Y Zheng; X F Zhou Journal: Neurotox Res Date: 2014-11-04 Impact factor: 3.911
Authors: Dirson João Stein; Klaus A Miczek; Aldo Bolten Lucion; Rosa Maria Martins de Almeida Journal: Psychopharmacology (Berl) Date: 2013-07-05 Impact factor: 4.530
Authors: Linda Booij; Dongsha Wang; Mélissa L Lévesque; Richard E Tremblay; Moshe Szyf Journal: Philos Trans R Soc Lond B Biol Sci Date: 2013-02-25 Impact factor: 6.237
Authors: Gregory L Stuart; John E McGeary; Ryan C Shorey; Valerie S Knopik; Kayla Beaucage; Jeff R Temple Journal: Violence Against Women Date: 2014-04
Authors: Amy P Ross; Katharine E McCann; Tony E Larkin; Zhimin Song; Zachary A Grieb; Kim L Huhman; H Elliott Albers Journal: Horm Behav Date: 2019-08-29 Impact factor: 3.587
Authors: Marta Rodríguez-Arias; Francisco Navarrete; M Carmen Blanco-Gandia; M Carmen Arenas; María A Aguilar; Adrián Bartoll-Andrés; Olga Valverde; José Miñarro; Jorge Manzanares Journal: Psychopharmacology (Berl) Date: 2015-04-29 Impact factor: 4.530
Authors: Klaus A Miczek; Joseph F DeBold; Lara S Hwa; Emily L Newman; Rosa M M de Almeida Journal: Ann N Y Acad Sci Date: 2015-08-18 Impact factor: 5.691
Authors: Marco Bortolato; Sean C Godar; Simone Tambaro; Felix G Li; Paola Devoto; Marcelo P Coba; Kevin Chen; Jean C Shih Journal: Neuropharmacology Date: 2013-07-16 Impact factor: 5.250